References
Drossman DA.
Treatment for bacterial overgrowth in the irritable bowel syndrome.
Ann Intern Med. 2006;145(8):626-628.
Halvorson HA, Schlett CD, Riddle MS.
Postinfectious irritable bowel syndrome—a meta-analysis.
Am J Gastroenterol. 2006;101(8):1894-1899.
Irritable bowel syndrome.
American Society of Colon and Rectal Surgeons website. Available at:
https://www.fascrs.org/patients/disease-condition/irritable-bowel-syndrome-0. Update October 2012. Accessed December 19, 2014.
Irritable bowel syndrome (IBS). EBSCO DynaMed website. Available at:
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS. Updated March 14, 2016. Accessed September 28, 2016.
Irritable bowel syndrome.
National Institute of Diabetes and Digestive and Kidney Diseases website. Available at:
http://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/irritable-bowel-syndrome/Pages/overview.aspx. Updated June 25, 2014. Accessed December 19, 2014.
Murch S. Allergy and intestinal dysmotility—evidence of genuine causal linkage?
Curr Opin Gastroenterol. 2006;22(6):664-668.
Probiotics for irritable bowel syndrome. EBSCO DynaMed Plus website. Available at:
http://www.dynamed.com/topics/dmp~AN~T474265/Probiotics-for-irritable-bowel-syndrome. Updated February 27, 2015. Accessed September 28, 2016.
Rubin G, De Wit N, Meineche-Schmidt V, et al.
The diagnosis of IBS in primary care: consensus development using nominal group technique.
Family Practitioner. Fam Pract. 2006;23(6):687-692.
Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study.
Gut.1998;42(1): 47-53.
Yan F, Polk DB. Probiotics as functional food in the treatment of diarrhea.
Curr Opin Clin Nutr Metab Care. 2006;9(6):717-721.
9/26/2006 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Mueller-Lissner S, Tytgat GN, Paulo LG, et al. Placebo-and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain.
Aliment Pharmacol Ther. 2006;23(12):1741-1748.
4/10/2007 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: US Food and Drug Administration. FDA announces discontinued marketing of GI drug, Zelnorm, for safety reasons. March 30, 2007. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108879.htm. Accessed December 19, 2014.
1/6/2009 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
BMJ
.
2008;337:a2313.
10/9/2009 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Lee S, Wu J, Ma YL, et al. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study.
Aliment Pharmacol Ther.
2009;30(6):643-651.
11/4/2009 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Ford AC, Brandt LJ, Young C, et al. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis.
Am J Gastroenterol.
2009;104(7):1831-1843.
1/11/2010 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Wittmann T, Paradowski L, Ducrotté P, Bueno L, Andro Delestrain MC. Clinical trial: efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome: results of a randomized, double-blind, placebo-controlled study.
Aliment Pharmacol Ther.
2010;31(6):615-624.
7/16/2010 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Dorn SD. Systematic review: self-management support interventions for irritable bowel syndrome.
Aliment Pharmacol Ther. 2010;32(4):513-521.
1/14/2011 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
N Engl J Med.
2011;364(1):22-32.
4/22/2011 DynaMed Plus Systematic Literature Surveillance
hthttp://www.dynamed.com/topics/dmp~AN~T113627/Irritable-bowel-syndrome-IBS: Johannesson E, Simrén M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial.
Am J Gastroenterol.
2011;106(5):915-922.